Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Clinical trial NCT04097561 · RECRUITING
Trial details
- NCT number
- NCT04097561
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2027-03-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.